Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.37 |
| ▸ | GAPDH | P04406 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 4/20 | 0.36 |
| ▸ | PPM1B | O75688 | 1/20 | 0.36 |
| ▸ | HRAS | P01112 | 1/20 | 0.35 |
| ▸ | F11 | P03951 | 1/20 | 0.34 |
| ▸ | ANTXR2 | P58335 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18067749 | 1.00 | ALDH1A1 (0.40) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL16731402 | 0.90 | PTPN1 (0.45) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL18045630 | 0.90 | PTPN1 (0.45) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL20990763 | 0.88 | LGALS3 (0.40) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL20990765 | 0.88 | LGALS3 (0.40) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL8954414 | 0.84 | UPP1 (0.42) | ALDH1A1POLBGAAMAPK1NPSR1 | |
| SCHEMBL18067751 | 0.81 | CYP2D6 (0.39) | — | |
| SCHEMBL18067731 | 0.81 | CYP2D6 (0.39) | — | |
| SCHEMBL19036055 | 0.81 | PTPN1 (0.50) | ALDH1A1POLBMAPK1MEN1USP2 | |
| SCHEMBL18067737 | 0.81 | PTPN1 (0.53) | ALDH1A1POLBGAAMAPK1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160264609-A1 | DISACCHARIDE INTERMEDIATE AND SYNTHESIS METHOD THEREOF | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2016-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160264609-A1 | DISACCHARIDE INTERMEDIATE AND SYNTHESIS METHOD THEREOF | SI, FUT5, HPSE | ALDH1A1 1664/4885POLB 3363/4885GAA 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.